1. Ucbbiopharma Srl (9 from 109 patents)

2. Ucb Biopharma Sprl (8 from 138 patents)

3. Sanofi (5 from 1,455 patents)

1. 12410161 - Tetrahydrobenzo-quinoline sulfonamides derivative compounds

2. 11912721 - Fused pentacyclic imidazole derivatives

3. 10953019 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

4. 10906919 - Fused pentacyclic imidazole derivatives

5. 10793578 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

6. 10766906 - Fused hexacyclic imidazole derivatives as modulators of TNF activity

7. 10669286 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

8. 10669263 - Substituted benzimidazole derivative as a modulator of TNF activity

9. 10654861 - Fused pentacyclic imidazole derivatives as modulators of TNF activity

10. 10472362 - Fused tricyclic imidazo pyrazines as modulators of TNF activity

11. 10202405 - Fused pentacyclic imidazole derivatives

12. 10093652 - Tetrahydrobenzimidazole derivatives as modulators of TNF activity

13. 10087179 - Fused tricyclic imidazole derivatives as modulators of TNF activity

14. 9969728 - Tetrahydroimidazopyridine derivatives as modulators of TNF activity

15. 9932343 - Fused tricyclic benzimidazoles derivatives as modulators of TNF activity